Radiomic CT features for evaluation of EGFR and KRAS mutation status in patients with advanced NSCLC

被引：4
|
作者：
De Jong, E. E. C. [1 ]
Van Elmpt, W. [1 ]
Hendriks, L. E. L. [2 ]
Leijenaar, R. T. H. [1 ]
Dingemans, A. M. C. [2 ]
Lambin, P. [1 ]
机构：
[1] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol,MAASTRO Clin, Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Pulmonol, Maastricht, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 119卷
关键词：
D O I：
10.1016/S0167-8140(16)31859-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0609
引用
收藏
页码：S290 / S291
页数：2
相关论文
共 50 条
  • [21] Correlation Between EGFR Mutation Status and Computed Tomography Features in Patients With Advanced Pulmonary Adenocarcinoma
    Hsu, Jui-Sheng
    Huang, Ming-Shyan
    Chen, Chiao-Yun
    Liu, Gin-Chung
    Liu, Ta-Chih
    Chong, Inn-Wen
    Chou, Shah-Hwa
    Yang, Chih-Jen
    [J]. JOURNAL OF THORACIC IMAGING, 2014, 29 (06) : 357 - 363
  • [22] EGFR Mutation Analysis in ct-DNA From NSCLC Patients
    Saetta, A.
    Chatziandreou, I.
    Chatziandreou, I.
    Giannopoulou, I.
    Michelli, M.
    Karamouzis, M. V.
    Tsikalakis, S.
    Patsouris, E.
    Kavantzas, N.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (02): : S52 - S52
  • [23] Radiomic Signature on CT Images: A Noninvasive Biomarker for Pretreatment Discrimination of EGFR Mutations in NSCLC Patients
    Kahya, Y.
    Orhan, K.
    Buyukceran, E. U.
    Gumustepe, E.
    Ozakinci, H.
    Koksoy, E. B.
    Ibrahimov, F.
    Baloglu, S.
    Coruh, A. Gursoy
    Akyurek, S.
    Sak, S. Dizbay
    Cangir, A. Kayi
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S519 - S520
  • [24] Relation of EGFR and KRAS mutation status with phosphorylation of EGFR in lung adenocarcinomas
    Brcic, L.
    Popper, H.
    [J]. VIRCHOWS ARCHIV, 2016, 469 : S327 - S327
  • [25] ERCC1 MRNA EXPRESSION AND KRAS MUTATION STATUS IN EGFR WILD TYPE (WT) ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Metro, Giulio
    Cenci, Matteo
    Siggillino, Annamaria
    Chiari, Rita
    Tofanetti, Francesca R.
    Giannarelli, Diana
    Pistola, Lorenza
    Flacco, Antonella
    Bennati, Chiara
    Bellezza, Guido
    Baglivo, Sara
    Sidoni, Angelo
    Ludovini, Vienna
    Crino, Lucio
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S794 - S794
  • [26] Application of CT radiomics features to predict the EGFR mutation status and therapeutic sensitivity to TKIs of advanced lung adenocarcinoma
    Yang, Chunsheng
    Chen, Weidong
    Gong, Guanzhong
    Li, Zhenjiang
    Qiu, Qingtao
    Yin, Yong
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (11) : 6683 - 6690
  • [27] CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses
    Mei, Dongdong
    Luo, Yan
    Wang, Yan
    Gong, Jingshan
    [J]. CANCER IMAGING, 2018, 18
  • [28] CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses
    Dongdong Mei
    Yan Luo
    Yan Wang
    Jingshan Gong
    [J]. Cancer Imaging, 18
  • [29] TREATMENT OF NSCLC PATIENTS WITH EGFR MUTATION
    Yang, J. C. -H.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 29 - 29
  • [30] KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer
    Boeck, Stefan
    Jung, Andreas
    Laubender, Ruediger P.
    Neumann, Jens
    Egg, Rosalind
    Goritschan, Clara
    Ormanns, Steffen
    Haas, Michael
    Modest, Dominik P.
    Kirchner, Thomas
    Heinemann, Volker
    [J]. JOURNAL OF GASTROENTEROLOGY, 2013, 48 (04) : 544 - 548
12345